Seroprevalence of and risk factors associated with hepatitis B, hepatitis C, and human immunodeficiency virus among prisoners in Iran

Infectious Diseases in Clinical Practice

Volumn 15, Issue 6, 2007, Pages 368-372

  Pourahmad, Morteza ^a   Javady, Abbassali ^b   Karimi, Iraj ^b   Ataei, Behrooz ^b   Kassaeian, Nazila ^b  

^a JAHROM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; IRAN; MAJOR CLINICAL STUDY; MALE; PRISONER; RISK FACTOR; SEROPREVALENCE; TATTOO;

EID: 36348985457     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/IPC.0b013e318142ce16     Document Type: Article

References (38)

1. Koziel MJ, Siddiqui A. Hepatitis B virus and hepatitis delta virus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2005;1864-1890.
2. Merat S, Malekzadeh R, Rezvan H, et al. Hepatitis B in Iran. Arch Intern Med. 2000;3:192-201.
3. Guimaraes T, Granato CF, Verella D, et al. High prevalence of hepatitis C infection in a Brazillian prison: identification of risk factors for infection. Braz J Infect Dis. 2001;5(3):111-118.
4. Stauber R. Epidemiology and transmission of hepatitis C. Wien Med Wochenschr. 2000;150(23-24):460-462.
5. Thomas DL, Ray SC, Lemon SM. Hepatitis C. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2005;1950-1981.
6. Hakimzadeh K. Guidelines for the Prevention of Transmission of HBV, HCV, and HIV in Healthcare Settings. 1st ed. Tehran: Nashr Seda Press; 2001:4-8.
7. Hajiani E, Masjedizadeh R, Hashemi J, et al. Hepatitis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. World J Gastroenterol. 2006;21;12(43):7025-7028.
8. Alizadeh AH, Alavian SM, Jafari K, et al. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamadan-Iran. World J Gastroenterol. 2005;11(26):4085-4089.
9. Malekzadeh R, Khatibian M, Rezvan H. Viral hepatitis in Iran and the world: epidemiology, diagnosis, treatment and prevention. J Med Council of IRI. 1998;15(4):183-189.
10. Merson MH, Piot P. Global perspectives on human immunodeficiency virus infection and acquired immunodeficiency syndrome. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2005:1465-1477.
11. UNAIDS. Middle East and North Africa Fact Sheet: Geneva; 2005;1-2.
12. Unicef. Islamic Republic of Iran. HIV/AIDS in Iran, 2006. Available at: http://www.unicef.org/Iran/media_2016.html. Accessed June 22, 2006.
13. Field MG. HIV and AIDS in the former Soviet Bloc. N Engl J Med. 2004;(351):117-120.
14. Christensen PB, Krarup HB, Niesters HG, et al. Prevalence and incidence of bloodborne viral infections among Danish prisoners. Eur J Epidemiol. 2000;16(11):1043-1049.
15. Weild AR, Gill ON, Bennett D, et al. Prevalence of HIV, hepatitis B and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health. 2000;3(2):121-126.
16. Zamani S, Kihara M, Gouya MM, et al. Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS. 2005;29;19(7):709-716.
17. Malliori M, Sypsa V, Psichogiu M, et al. A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction. 1998;93(2):243-251.
18. Macalino GE, Viahov D, Sanford-Colby S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;94(7):1218-1223.
19. Decker MD, Vaughn WK, Brodie JS, et al. Seroepidemiology of hepatitis B in Tennessee prisoners. J Infect Dis. 1984;150(3):450-459.
20. Chiramonte M, Trivello R, Renzulli G, et al. Hepatitis B virus infection in prisons. A seroepidemiological survey in prisoners and attending staff. J Hyg (Lond). 1982;89(1):53-58.
21. Crofts N, Stewart T, Hearne P, et al. Spread of bloodborne viruses among Australian prison entrants. Br Med J. 1995;310(6975):285-288.
22. Stark K, Herrmann U, et al. A syringe exchange program in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany. Epidemiol Infect. 2006;134(4):814-819.
23. Weber U, Schneider W. Syringe exchange in Germany. Subst Use Misuse. 1998;33(5):1093-1112.
24. Dolan KA, Wodak A. HIV transmission in a prison system in an Australian state. Med J Aust. 1999;171(1):14-17.
25. Dolan K, Rutter S, Wodak AD. Prison-based syringe exchange programs: a review of international research and development. Addiction. 2003;98(2):153-158.
26. Jurgens R. Another review of prison-based needle exchange programs published. Can HIV AIDS Policy Law Rev. 2004;9:46.
27. Dolan KA, Biji M, White B. HIV education in a Siberian prison colony for drug dependent males. Int J Equity Health. 2004;21;3(1):7.
28. Samuel MC, Doherty PM, Bulterys M, et al. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect. 2001;127(3):475-485.
29. Hellard ME, Hocking JS, Crofts N. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect. 2004;132(3):409-415.
30. Babudieri S, Longo B, Sarmati L, et al. Correlates of HIV, HBV and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol. 2005;76(3):311-317.
31. Hajiani E, Hashemi J, Masjedizadeh R, et al. Seroepidemiology of hepatitis C and its risk factors in Khuzestan province, southwest of Iran: a case-control study. World J Gastroenterol. 2006;12(30):4884-4887.
32. Loimer N, Werner E. Tattooing and high risk behaviour among drug addicts. Med Law. 1992;11(3-4):167-174.
33. Sawayama Y, Hayashi J, Kakuda K, et al. Hepatitis C virus infection in institutionalized psychiatric patients: possible role of transmission by razor sharing. Dig Dis Sci. 2000;45(2):351-356.
34. Adjei AA, Armah HB, Gbagbo F, et al. Correlates of hepatitis C virus infection among incarcerated Ghanaians: a national multicentre study. J Med Microbiol. 2007;56(3):391-397.
35. Beyrer C, Jittiwutikarn J, Teokul W, et al. Drug use, increasing incarceration rates, and prison-associated HIV risks in Thailand. AIDS Behav. 2003;7(2):153-161.
36. Hacker MA, Friedman SR, TElles PR, et al. The role of "long term" and "new" injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil. Subst Use Misuse. 2005;40(1):99-123.
37. Mackenzie AR, Laing RB, Urbaniak SJ, et al. Epidemiology and outcome of HIV infection in North-East Scotland (1985-1997). J Infect. 1999;(2):107-110.
38. Crofts N, Hay M. Entry of HIV infection into a population of injecting drug users. Med J Aust. 1991;16;155(6):378-382.